Oligogen
Oligogen Inc. is a pioneering biotech venture dedicated to innovative research and development in regenerative medicine and drug discovery. Their mission is to create a future that significantly enhances human prosperity through cutting-edge gene research and biotechnology, aiming to establish a healthcare platform that promotes foundational research and supports a healthy, secure life for all. They collaborate with universities and pharmaceutical companies worldwide to develop new treatments and improve society.
Industries
Nr. of Employees
small (1-50)
Oligogen
612-8374 Kyoto, Fushimi-ku, Jibu-cho 105, Kyoto City Growth Industry Creation Center (ACT Kyoto) 507
Products
Cell Therapy for Pelizaeus-Merzbacher Disease
A treatment approach using cell therapy to address Pelizaeus-Merzbacher disease, a rare genetic disorder affecting the central nervous system.
Cell Therapy for Multiple Sclerosis
A therapeutic method employing cell therapy to treat multiple sclerosis, a chronic illness that affects the brain and spinal cord.
Cell Therapy for Spinal Cord Injury
A treatment utilizing cell therapy to aid in the recovery and repair of spinal cord injuries.
Exosome Therapy
A therapeutic approach using exosomes, which are small vesicles released by cells, for various medical conditions.
Drug Development
The process of discovering and developing new drugs using stem cell technology.
Cell Therapy for Alzheimer's Disease
A treatment method using cell therapy to address Alzheimer's disease, a progressive neurological disorder.
Cell Therapy for Pelizaeus-Merzbacher Disease
A treatment approach using cell therapy to address Pelizaeus-Merzbacher disease, a rare genetic disorder affecting the central nervous system.
Cell Therapy for Multiple Sclerosis
A therapeutic method employing cell therapy to treat multiple sclerosis, a chronic illness that affects the brain and spinal cord.
Cell Therapy for Spinal Cord Injury
A treatment utilizing cell therapy to aid in the recovery and repair of spinal cord injuries.
Exosome Therapy
A therapeutic approach using exosomes, which are small vesicles released by cells, for various medical conditions.
Drug Development
The process of discovering and developing new drugs using stem cell technology.
Cell Therapy for Alzheimer's Disease
A treatment method using cell therapy to address Alzheimer's disease, a progressive neurological disorder.
Services
Collaborative research and preclinical development of neural stem cell–derived therapeutics targeting demyelinating and neurodegenerative conditions and spinal cord injury.
Research and preclinical formulation development of exosome-based candidates for neurological indications with the aim of producing license-ready assets.
Provision of phenotypic screening and in vitro assay development using human neural cell models to identify lead compounds and assess safety/efficacy in early discovery.
Development of GMP-compatible manufacturing processes and master cell bank production methods for clinical‑grade neural cell materials, including associated quality controls.
Collaborative research and preclinical development of neural stem cell–derived therapeutics targeting demyelinating and neurodegenerative conditions and spinal cord injury.
Research and preclinical formulation development of exosome-based candidates for neurological indications with the aim of producing license-ready assets.
Provision of phenotypic screening and in vitro assay development using human neural cell models to identify lead compounds and assess safety/efficacy in early discovery.
Development of GMP-compatible manufacturing processes and master cell bank production methods for clinical‑grade neural cell materials, including associated quality controls.
Expertise Areas
- Cell therapy development for neurological disorders
- Exosome-based therapeutic development
- Phenotypic cell-based drug discovery using human neural cells
- GMP manufacturing and master cell bank production for clinical materials
Key Technologies
- Human neural stem cell–derived therapeutics
- Exosome formulation and delivery methods
- Phenotypic cell-based screening platforms
- In vitro disease-model assays for neurodegeneration
News & Updates
Participated and presented at the 10th-anniversary forum of ACT Kyoto, highlighting their contributions to industry-academia collaboration.
Featured as a promising company in Kyoto City, showcasing their advanced technologies.
Participated and presented at the 10th-anniversary forum of ACT Kyoto, highlighting their contributions to industry-academia collaboration.
Featured as a promising company in Kyoto City, showcasing their advanced technologies.